The cell and gene therapy session highlights curative programs targeting single-gene defects such as haemophilia, muscular dystrophy, and immunodeficiencies. These therapies are targeting the underlying genetic defect rather than the management of symptoms—moving from long-term management toward long-term correction and functional recovery.
Regenerative Medicine Conferences 2026 Researchers and clinicians are expected to discuss future healthcare innovations